Upon AMPK re-expression, AMPK KO cells were significantly targeted by venetoclax, in favor of a positive contribution of AMPK expression in the early apoptotic response induced by Bcl-2 inhibition in AML (Figure 4C). The gene discussed is PRKAA2; the disease is acute myeloid leukemia.